|
|
Volumn 354, Issue 19, 2006, Pages 2076-2077
|
|
Coronary-artery stents [16]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORONARY STENT;
HEART INFARCTION;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
THROMBOSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
STENT;
SURVIVAL RATE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
CORONARY ARTERY THROMBOSIS;
HYPERSENSITIVITY;
PROGNOSIS;
IMMUNOSUPPRESSIVE AGENT;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ARTERY BYPASS;
CORONARY DISEASE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
RANDOMIZED CONTROLLED TRIALS;
STENTS;
SURVIVAL RATE;
CORONARY THROMBOSIS;
HYPERSENSITIVITY;
ASPIRIN;
PLATELET AGGREGATION INHIBITORS;
PROGNOSIS;
|
|
EID: 33646468381
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/nejmc060570 Document Type: Letter |
|
Times cited : (15)
|
|
References (1)
|
